Short and long-term clinical outcomes of use of beta-interferon or glatiramer acetate for people with clinically isolated syndrome : a systematic review of randomised controlled trials and network meta-analysis

Armoiry, XavierKan, AlanMelendez-Torres, G. J.Court, RachelSutcliffe, PAuguste, PeterMadan, JasonCounsell, CarlClarke, A.2018-01-222018-01-222018-05Armoiry, X, Kan, A, Melendez-Torres, G J, Court, R, Sutcliffe, P, Auguste, P, Madan, J, Counsell, C & Clarke, A 2018, 'Short and long-term clinical outcomes of use of beta-interferon or glatiramer acetate for people with clinically isolated syndrome : a systematic review of randomised controlled trials and network meta-analysis', Journal of Neurology, vol. 265, no. 5, pp. 999-1009. https://doi.org/10.1007/s00415-018-8752-80340-5354ORCID: /0000-0001-6622-7839/work/164505662http://hdl.handle.net/2164/9920Source of funding: This work is part of a larger report commissioned by the NIHR HTA Programme as project number ID809. A.C. and G.J.M.T. are partly supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care West Midlands at the University Hospitals Birmingham NHS Foundation Trust.111699380engMultiple sclerosisclinically isolated syndromebeta-interferonglatiramer acetatesystematic reviewR Medicine (General)National Institute for Health Research (NIHR)R1Short and long-term clinical outcomes of use of beta-interferon or glatiramer acetate for people with clinically isolated syndrome : a systematic review of randomised controlled trials and network meta-analysisJournal article10.1007/s00415-018-8752-82655